Flotek Industries, Inc. (FTK) Earnings Call Transcript & Summary

November 9, 2021

New York Stock Exchange US Materials Chemicals earnings 48 min

Earnings Call Speaker Segments

Nick Bigney

executive
#1

Thanks, and good morning to all of you; we're glad you could join us today. With me on this call and taking part are John Gibson, our Chairman, Chief Executive Officer and President; Michael Borton, our Chief Financial Officer; TengBeng Koid, President of Data Analytics; and Ryan Ezell, President of Chemistry Technologies. During this call, we'll start with prepared remarks about our business and the results for the quarter. After that, we'll take whatever questions you might have. Our earnings announcement for the third quarter came out yesterday, and you can find it on our website. This call is being webcast, and a replay will be posted on our website as well. Before we get started, please be aware that anything we say today about projections or what we expect for future events counts as forward-looking statements. Such statements carry a number of risks and uncertainties, many of which we cannot control and which may cause actual results to differ materially from what we currently expect, so we encourage listeners to review our earnings releases and the risk factors covered in our SEC filings. In addition, please look at the reconciliations included in our earnings release, since we might talk about non-GAAP metrics on this call; and now I'll hand things over to John.

John Gibson

executive
#2

Thanks, Nick, and good morning to everyone. Our results in Q3 show how we're carrying out the plan to speed up sales for chemistry technology and data analytics while also putting effort into clearing up the legacy problems we still have. I'll cover all of that. Throughout the third quarter, we've put in a lot of effort to increase revenues. I'm happy to share that our third-quarter revenues came in roughly 11% higher than what we saw in the second quarter. Looking at how some of the bigger oilfield service companies grew their revenue, the improvement from Q2 looks fairly modest. We think our sequential numbers stacked up well when compared with our peers. Later in this call, Mike Borton will take you through the financial figures and provide more detail. Making our sales strategy work has been something we've prioritized as we come out of COVID. And we've already felt a favorable effect. On our Q2 call, I told you we had cut costs in some areas so we could put that money back into our sales team. That choice has been carried out, and I can share that as of today we've added 11 new sales professionals — eight supporting the chemistry business and three working on data analytics. All of these individuals bring deep experience, a demonstrated history of success, and significant sales quotas from their prior positions, and hopefully they'll deliver here too. The connections they have across the industry will assist us in carrying out our go-to-market strategy. We keep energizing our sales work with ECT, and what we've seen is clear growth and greater diversity in that segment's revenues; luck was also on our side in Q3 when Hurricane Ida went almost straight across a rail spur in Louisiana. Damage there was very limited, and we kept operating, which helped the industry and especially our customers; we think staying operational gives that facility upside potential, and over the coming few quarters we anticipate solid performance in ratio. Beyond those new sales professionals I just mentioned, our ProChem business has entered into four strategic agreements with manufacturing representation companies. In the end, what these deals provide is instant reach to a large sales force across a wide geography. These partnerships matter to our approach of using an indirect sales channel to open up more targeting opportunities. This isn't an approach we came up with ourselves. Companies such as Clorox, Gojo, and 3M are well established and use this model effectively, and we aim to follow suit. We think this specific strategy offers us a great deal when it comes to reducing the cost of execution relative to what we might gain. Ryan will provide you with additional detail on the sales and revenue transfer ECT, along with a few more highlights on ProChem's achievements during the last quarter. ECT and ProChem both had plenty going on in Q3, and not to be left out, JP3 put out two major press releases regarding product deployment and new patent pending technology. We kicked things off by announcing the launch of the AIDA application — a machine learning, AI-driven application that has us quite enthusiastic. The subsequent announcement had to do with international certification for our online analyzers, something all of us have been waiting for. I'll turn it over to Koid to provide additional detail on those announcements. In our view, those 2 rollouts will assist us in making progress toward the objectives we've laid out: growing sales internationally and achieving profitable revenue growth overall. At present, we keep observing a reasonable level of consolidation within M&A activity in our space — for instance, next year's acquisition of Alamo Pressure Pumping, ProFrac's purchase of FTSI, and the recent merger of Wilks with Dawson Geophysical. We are actively assessing the M&A landscape and seeking opportunities that match our success criteria. Those criteria number 3: we would only look at transactions that are accretive quickly; where the cash needs involved will be backed by the market and shareholders; and last, the transaction must carry the potential to advance our sustainability objectives. Executing successfully on those sustainability objectives is an essential path toward our success, since I believe we are now headed toward broad adoption across our industry of an environmental culture spanning the entire sector. In today's world, a robust safety culture plus demonstrable metrics have turned into the minimum requirement in our industry — absent those, nobody regards you as a bidder. In the same way, ESG performance is going to become yet another element defining what attractive business partners look like. Without question, a company's ESG footprint shapes its access to capital. We observe robust adoption and philosophical alignment among board and C-suite levels; however, a certain amount of latency and translation into purchasing behavior persists at operational levels. Across the industry, embracing ESG principles along with the establishment and emergence of an environmental culture will probably happen swiftly in 2022. Flotek is positioned well to serve as the partner of choice for effective, responsible chemistry and data solutions. The modifications we undertook regarding our sales strategy capacity, together with the groundwork involving JP3, are going to be essential to setting ourselves apart in the marketplace as our customers' environmental cultures evolve. Supply chain uncertainty is a subject that has likewise drawn substantial media coverage recently, and we keep monitoring developments regarding the prospect of sanctions targeting China. Should sanctions be prolonged, they could shift drilling industry demand drastically — China right now produces and exports significant volumes of polyacrylamide and barium sulfate, both of which see wide use in the OFS industry and among operators. On top of that, inflationary pressures alongside transportation constraints may affect our customers by driving prices higher and adding to sourcing delays. These factors add complexity, yet they likewise create chances for us to collaborate with customers and craft mutually beneficial outcomes. We have put processes in place intended to help us track and adjust to numerous such macro environmental factors; we have invested in bolstering our own supply chain and logistics function. We've put in place a system meant to make the sharing of sales forecasts with supply flow more smoothly, and we have a group whose expertise lies in international agreements. Now, nearly everything I've said up to this point has focused on what we achieved during the quarter in our business. And on what we view as the road ahead, but I'd like to spend just a moment on one of the matters we inherited. As you're aware, when I came on board in 2020, I took on a terpene contract of a kind with Florida Chemical company that far exceeded what we required. At the close of 2020, we recorded 9.4 million in accrued liability for losses we anticipated taking on because of that contract. Earlier this year, we got drawn into litigation with Florida chemical and ADM. its parent company, and because of that contract and our request for an audit, we brought the litigation forward. During the litigation, we managed to locate a commercial counterpart at IBM and we succeeded in closing the matter out, settling the litigation last month. Under the settlement we consented to pay Florida Chemical 1.7 5 million and the terpene contract is confirmed terminated, along with the obligation to buy an additional 10.5 million pounds of terpene. That lets us release the 9.4 million accrued liability too, which Mike will explain further in his remarks. We appreciate IBM's readiness to enter a business negotiation with us. And we're glad to have this inherited matter behind us. Now, with that, I'd like to hand things over to TengBeng to cover data analytics. TengBeng ?

Teng Beng Koid

executive
#3

Thanks, John. Morning, everybody. Over in Data Analytics, we're still achieving a lot of headway abroad, which fits into our strategy for expansion. Like John said, we put out a press release not long ago about the fresh Verax lineup built for markets outside the US, named Verax ISX/IMX — both single channel and multi-channel versions. We secured industry certifications allowing use in hazardous locations around the world. These analyzers are built to run under severe operating conditions, such as an ambient temperature of 55 degrees C, which equals 131 degrees Fahrenheit. And contamination is typical in certain tough settings, including dust caused by sandstorms. Our pipeline of opportunities for this certified analyzer line is strong, since it unlocks international markets for us, and we anticipate shipping these new analyzers in 2022. Advanced data analytics represents yet another growth pillar for us. We issued a press release, which John brought up recently, about rolling out this new application that relies on advanced machine learning algorithms; this groundbreaking application lets pipeline operators tell apart two batches, or refined fields, traveling through a pipeline. This application, which has a patent pending, is named AIDA, or Advanced Interface Detection Algorithm, and it delivers real-time safeguarding of pipeline interfaces with no requirement for extra sampling or chemometric modeling. Pipeline operators will be certain and quick to know when a new batch has shown up. The value generated by this application is substantial, and we intend to release additional AI machine learning applications going forward. Although revenue fell sequentially because of seasonality, since the third quarter has historically been the lowest quarter for the year, revenue climbed 23% compared with the third quarter of last year; additionally, for certain applications, we're urging customers to shift toward a subscription model instead of making a capital purchase. And this drive toward the subscription model expanded field size growth considerably. That said, our annual recurring revenue keeps increasing, and we anticipate the trend will persist. John noted that we brought on three new sales professional as well, and we expect that will drive our growth further in 2022; with that, I'll pass it to Ryan to talk about the chemistry technology segment. Ryan?

Ryan Ezell

executive
#4

Thanks, Koid, and good morning, everyone. Today I'll walk through the results for our chemistry technology segment. I'll start by discussing our energy chemistry technologies, then move on to professional chemistries, which includes solutions for both industrial and consumer chemistry. As we wrap up Q3, I'm pleased to report that our strategy in energy chemistry technology — serving as the collaborative partner of choice to provide sustainable, optimized chemistry solutions — is being fully executed and gaining momentum. Flotek's differentiated offerings are designed to create maximum value for our customers by improving their ESG performance, reducing operational costs, and generating stronger return on invested capital. We continue to witness expansion among exploration and production companies both at home and abroad, as well as among service providers. That tells us we're making good on the pledge from Q2 to broaden where our revenue comes from and reduce exposure to having too few customers. Then, in Q3, we wrapped up the organizational adjustments tied to our accelerator initiative: we grew our sales team to twice its previous headcount, and along the way brought aboard more than 150 years of combined sector expertise that covers a range of specialties throughout the full energy value chain. Beyond that, we completed the transition to digital for our CRM platform, our web-based demand forecasting tools, and our geographic cost tracking systems that update in real time — all of which serve to boost efficiency and speed when going after customers. So, here's what we can share about the third quarter. First, energy chemistry technologies revenue is up almost 30% compared to the prior quarter, and we're growing much faster than the market overall, which tells us we're gaining share. Second, money coming in from new or non-core accounts rose 34%, and our customer count was up 22% versus the previous quarter — that shows we're still focused on reducing how much we depend on a few big customers and broadening where our revenue comes from. On top of that, we're making real headway rebuilding our indirect routes to market alongside service companies. We've locked in a partnership with a large international service company to run a four-wheel trial of Flotek's proprietary slick water hydraulic fracturing fluid system with a major NOC operator in Saudi Arabia. On top of that, we signed a five-year extension to a service agreement at the materials and trend logistics site we run in Raceland, Louisiana, together with one of the biggest oilfield services companies anywhere in the world, and at the same time we grew that piece of business despite what Hurricane Ida did. The segment also broke into a neighboring energy market successfully, bringing in revenue from geothermal drilling and cementing work. Then, wanting to keep risk down, we went ahead and started talking early with our main suppliers so we could lock in purchase prices for the future and the material allocation volumes tied to our leading product for 2022, since our eyes are on continuing to grow. To wrap up, we're excited to share that Flotek's ESG scorecard assessment is now commercially available. This tool examines chemical usage across the entire well cycle and pinpoints ways to help customers meet their ESG reporting objectives, improve operational efficiency, and manage enterprise risk. Switching over to our professional chemistries segment: in Q3, we made meaningful strides and moved this product line toward lasting success. With chemistry positioned as the core of our operations, our synergistic approach enables the company to leverage shared assets, supply chain, logistics, and technical teams so we can connect with buyers and markets that are distinctly adjacent. That gives us the flexibility to pivot toward whichever opportunities appear most promising. It's encouraging to watch these categories diversify and gather momentum, since they'll drive our expansion as the collaborative partner of choice for sustainable chemistry solutions that deliver maximum value to our customers. Since we last reported, here's what we've accomplished in our professional chemistry segment. To start, we entered into 3 contract manufacturing and toll blending agreements with suppliers located in the U.S. On top of that, we expanded our sales force through manufacturing representations with 4 agencies, giving us nationwide reach across 48 states and more than 150 sales representatives. I want to emphasize one key point: our professional chemistries line operates on an indirect, commission-driven model. That approach lets us reach a broader market faster while needing much less upfront capital. On top of that, we expanded our offerings by introducing 18 private label auctions serving distribution and redistribution groups. Finally, we generated sales from a sector next to agriculture via our green solvents and adjuvant applications. To be candid, our enthusiasm about the continuing possibilities within the chemistry technology segment couldn't be greater, and we're eager for what lies ahead as we continue enabling our customers' social license to operate through our improved chemistry solutions. With that, I'll turn things over to Mike, who will take us through the financial results.

Mike Borton

executive
#5

Thanks, Ryan. Good morning, everybody. I'll now go over how we did financially this quarter. Consolidated revenue for the quarter came in at 10.2 million, which is an 11% increase in Q2 — and that's comfortably above the 12.7 million we brought in during Q3 of 2020. Looking at it by segment, chemistry technologies posted 9.4 million in revenue for the third quarter, which is a 20% gain over Q2, but a 22% drop versus Q3 2020. The falloff in chemistry compared with Q3 2020 came mainly from lower sales activity tied to losing a big customer back in our second quarter; we also experienced a sizable decrease in sanitizer sales relative to a year earlier. Those declines were partly made up for by a number of new customers as well as returning ones during the third quarter. Moving on to data analytics, revenue of <<inaudible>> rose 23% compared with the third quarter of 2020, even though it came in under the 1.5 million recorded in the second quarter. Historically, the third quarter tends to be the weaker one for data analytics. On a consolidated basis, operating expenses totaled 5.4 million in Q3, down 55% from the previous quarter and 82% below the prior year's figure of 29.5 million for the third quarter. The sequential drop in operating expenses was mainly attributable to the net effect of the $9.4 million release of ADM access terpene loss reserves, which was offset by the 1.75 million pending payment. Higher material costs tied to the quarter's greater revenue partly counteracted that reduction in operating expenses. Expenses in Q3 2020 were obviously elevated because of $9.6 million of E&L <<inaudible>> reserves connected to last year's product rationalization plus $3.2 million related to the JP3 earnout provision. Corporate G&A for the third quarter was 2.7 million, representing a 7% decrease from the prior quarter. That drop stems largely from releasing the 2020 bonus accruals along with the severance accrual taken in the prior quarter. On top of that, the employee retention credit was bigger in the second quarter since it included catch-up credits for Q1. G&A also carries an accrual covering all the remaining ADM legal fees tied to the settlement. We're reporting profit from continuing operations of 509,000, or $0.01 profit per diluted share, for the third quarter. That stacks up against a $0.09 loss per diluted share in the second quarter. These current quarter results mark a major improvement compared with the loss of 45.2 million, or $0.66 cent loss per diluted share, in the third quarter of 2020. The ADM settlement affected current earnings per diluted share by about $0.11 cents, while Q3 2020 EPS carried the negative impact of the JP3 impairment at $0.36, inventory rationalization at $0.14 cents, and the JP3 earnout provision at $0.05. For Q3, adjusted EBITDA came in as a loss of 6.3 million, which is better than the 6.7 million loss we posted in Q2 and the 6.5 million loss from a year ago. Turning now to the balance sheet: our priority there stays the same — safeguarding and strengthening liquidity. We closed Q3 with 20.5 million in cash equivalents, compared with 27.8 million at the end of Q2. Operating losses weighed on our cash, along with customers pushing out payment terms, mainly those outside the U.S. A 23% drop in net inventory levels gave our cash position a lift. When it comes to payments, we're noticing that certain customers are being prioritized and are accepting improved terms on select products of ours. Late in September, Flotek filed with the SBA, seeking forgiveness for almost the entire 4.8 million of PPP loans still sitting on the balance sheet. Also, late in October, we got the green light to repay whatever PPP loan amounts aren't forgiven across five years, rather than two. Beyond that, due diligence continues on an asset baseline, which will be tapped to finance working capital growth as the business grows. And finally, we signed long-term leases for both the Waller and Monahan facilities. We've also brought on a national real estate firm to market a number of our facilities for sale, and to help with subleasing or renegotiating one of our facility leases. On the balance sheet you'll also find the settlement payments owed to ADM, payables, and related outside legal fees, all of which will be settled across the coming two quarters. The balance sheet additionally carries a $1.9 million balance tied to the employee retention credit, which will go toward lowering future cash outlays for employee payroll taxes. Last, an update on remediation of the 2020 material weaknesses we reported earlier: progress has been very good all year as we've carried out the remediation plan. First off, we tightened control over the program by moving internal audit management in house. The accounting and finance team also put in place certain new controls and is working to boost operating effectiveness of our key controls in the material weakness areas. Testing is underway and will run into Q4. We anticipate being fully remediated by December 31. With that, I'll hand things back to John for closing remarks.

John Gibson

executive
#6

Thanks, Mike, Ryan, and TengBeng. During the Q3 2020 call a year ago, the vast majority of folks would basically head home for Thanksgiving and stay away until January's second week. Those comments drew a lot of flak my way. Still, I believe Mark's statements turned out to be accurate. This time around, though, crude prices are rising more quickly than many of us would have gotten involved. As a matter of fact, the price kept climbing across the bulk of Q3, and it remains strong right now. WTI reached $85 per barrel back in October — the first occasion it hit that mark since 2014. And at present, my confidence is much greater that activity levels will stay consistent, grow, and carry on right through the Christmas holidays, possibly beyond. All the favorable developments and steady economic gains we're witnessing have us excited. We're also sure Flotek is positioned well to keep delivering our value added products and services as activity keeps speeding up, and that embracing an environmental culture will give us a solid base for growth ahead. There's one elephant in the room — I'll attempt to tackle it on our next call, when you hear from us on the year-end Q4, which will mainly center on how we're executing the current strategy to secure the cash we require going forward. That will form the principal element of our next call as we lay out what we've done and what we're doing so that we remain a going concern. We're thrilled about what's available to us for carrying that out; to close, let me thank our team members, our customers, and especially our shareholders for all their continued support; and with that, we're going to open it up to questions.

Eric Swergold

analyst
#7

I'm going to pose a single large question, and after that I'll rejoin the queue, since I realize quite a few folks have questions; however, could you provide some detail regarding how many companies, and how big they are, that are either assessing or currently testing your chemistry or CNF from E&P players, global integrated, and state-owned oil companies, I believe it would be useful to have a sense of what targets you're aiming at. Thank you.

Ryan Ezell

executive
#8

Yes. I'll jump in on that. So looking at it today in terms of size, I'll begin by discussing the international markets and the campaigns we currently have running there. Like I said, we're pursuing a full fluids development alongside the major NOC players in Saudi Arabia. And beyond that, we've had complex nanofluid applications under trial with major and NOCs in Kuwait, plus the United Arab Emirates; and those keep building success and data improvement, and we're hoping to advance toward full field applications; we've also maintained growth and pursuits with several of the major players who are actually independent in the Permian Basin, the Anadarko basin, and in the DJ. And we've achieved strong performance in those trial tests up to now. We referenced a few of them during earlier quarters. But once more, from our standpoint, we're seeking these full field deployments that will help shift the needle for us in growth, and we're observing solid improvements there. And then, the last item I'll bring up is that alongside the line utilization of our complex nanofluids, we've likewise witnessed expansion into the remediation and water flooding markets; we're seeing some of those in Canada, and California too, plus robust remediation application in the Permian Basin; and those keep expanding at double-digit percentages quarter-on-quarter; so quite a lot of things. I hope this sort of distinctive mix of major independent and large NOCs in some of the — in the Middle East that are truly going to assist us in moving that needle with magnitude in 2022.

Daniel Burke

analyst
#9

Let's take a look. I suppose there are simply a couple of inquiries regarding the energy chemistry segment. Could you bring us up to speed on those two bigger clients that ran into trouble because of M&A? My understanding is there was an expectation, or at least a hope, that things would sort of be shored up by the close of the year. I was curious whether an update might be available if that's workable; and separately, I'm aware you folks have been trying to rebuild — or rather, I understand you've been trying to rebuild — your channel sales through other service providers into the oil field, so how is the restoration of those ties progressing?

Ryan Ezell

executive
#10

Regarding that, I'll begin by addressing the indirect channel markets as they stand today. We're witnessing excellent momentum in indirect channels, and if you were to set, say, Q3 of 2020 alongside Q3 of 2021, we've recorded a 47% gain in the service company applications coming to us by way of the indirect channel. What's more, we keep observing that growth even when measured against Q2. Looking at it, there are a good number of dimensions and paths we're pursuing for this — certain ones are what we'd call fully prescriptive chemistry that preserves every chemistry profile, certain ones involve our own engineering elements that we handle on the data analytics side for chemistry applications as a piece of that service, plus laboratory testing; so we're genuinely pleased with the direction this is heading. That's placing us in a solid position to pursue further, even alongside our E&P operators, into those indirect channels; now, about the remarks concerning those two major customers — looking at it, I'd say that of the pair, we're presently reengaging with one of them for what's ahead in 2022. As for the second one, it's an ongoing process at the moment. There are merely discussions, since activity at that location is minimal right now.

John Gibson

executive
#11

Daniel, honestly, that's an area where we're doing really well now. The kind of relationship problems we were dealing with 3 quarters back, I don't believe those exist anymore. We're a business, and all we have to do is deliver a great solution, and they're ready to purchase from us. At this point, nothing stands in the way of them buying. So over the past 12 months, I'd say we've made enormous strides in those relationships, which sets us up nicely moving forward.

Daniel Burke

analyst
#12

All right. So let me shift direction here and pose a question about JP3, the analyzer built for tougher environments. Practically speaking, does that open up any doors in the near term? I mean, once you recover from a few of the seasonal effects on the data side that hit in Q3, is the Q4 outlook noticeably better?

Teng Beng Koid

executive
#13

Thank you, Daniel. With this fresh analyzer, I'd say one of the largest hurdles we faced previously was that the certification our analyzer held covered North America only, not international markets. That meant we had to develop a replacement unit certified for international use. International certification runs through two separate organizations: ATEX is one, and IECEx is the other. Certain nations mandate ATEX certification, while others mandate IECEx, and that creates an international market opportunity for us that simply wasn't there previously. Beyond that, clearly we wanted an analyzer capable of withstanding every kind of condition, such as the severe heat you find in the Middle East, and pollution too, as you're aware. So we made certain we could secure certification for those conditions. Once that's in place, we're then able to serve the remaining nations across Asia, Africa, and Europe too. So all at once, a brand-new market becomes available to us. Our expectation is that we will likely ship a portion of these newer lines during 2022. So yes.

John Gibson

executive
#14

Daniel, thanks for raising that. Considering the sales process Koid is heading up, we had quite a few pilot projects ready to launch, yet deploying the hardware into those pilots wasn't possible before we obtained certification for it. With certification now secured, we move into the pilot phase, after which those pilots should turn into orders. So there's a strong pipeline in place. However, lacking certified VOCs for the settings where we were pursuing deals, sales cycles leave you unable to determine where they end. Now we can see where they begin. Pilots are kicking off, and watching the potential that JP3 has internationally is truly exciting. Honestly, the highlight of any discussion comes when you sit down and discuss digital transformation.

Daniel Burke

analyst
#15

Understood. All right, at this point I won't push further, everyone. John, we'll be watching for additional detail regarding liquidity down the road, just like you said; thanks for your time.

Jeff Robertson

analyst
#16

I appreciate the opportunity to ask. I believe TengBeng brought up shifting certain data analytic services toward a subscription approach. I'd like to know whether that would improve things — or rather, in what way do you anticipate that this would strengthen your revenue model, whether via greater customer uptake, more subscriptions, or extended relationships?

Teng Beng Koid

executive
#17

The core objective here is achieving annual recurring revenue over a longer horizon that can be counted on going forward; that's what we're aiming for. At present, we clearly continue to sell capital purchases. So certain applications are being moved over on a selective basis. Of course, whenever you transition away from a capital purchase toward a subscription, a decline in revenue will show up. Over the long run, though, that will recover.

John Gibson

executive
#18

It's a fascinating moment, Jeff. To put it plainly, we've got three different ways of selling that are functioning. The one we favor most is annual recurring revenue; the next would be a hybrid approach. Then there's the third, which involves selling equipment outright. Because our customers are folks who've already purchased a handful of units yet still could roll out much more of what we offer, the goal is moving them away from the equipment purchases they made in the past and toward either a hybrid arrangement or ARR. That's why we're guiding them across that journey. A number of them simply prefer to acquire hardware, since revenue matters enormously to us and so does cash. Koid and I regularly talk over the business judgment of whether to accept the hardware as-is, nudge them toward hybrid, or nudge them toward ARR. We're able to — letting a sale drag on too long isn't something we want. They aren't walking away from us; even so, a sales cycle does stretch out whenever you insist on ARR while they'd rather pick up equipment. So we're navigating that shift.

Jeff Robertson

analyst
#19

Jeff, here's the thing — does that approach expand how many possible buyers you'd have for analytics?

John Gibson

executive
#20

John: Well, it really hinges on the situation. What's fascinating is that, take Koid as an example too — certain nations aren't fans of ARR; their preference is simply acquiring hardware. They're built around buying capital equipment, putting it to work, and they have no interest in a subscription-style setup like you'd see with software companies. Paying maintenance isn't something they're set up for. Their preference is to purchase a license, then simply use it. Afterward, whenever an update is needed, they'd rather just make another purchase — that's what they'd favor. So absolutely, we must stay flexible toward whatever markets we sell into. Yet the upside of ARR is how sticky things become once they're on board — you're embedded, and much like SAP or some other ERP system, it's simply there on their desktop, functioning; they rely on it, and it becomes part of their business DNA. Our aim is to reach that point where it isn't merely equipment they might switch off, or when you swap out an operator, they no longer perceive any value in the measurement since it isn't woven into their process — so that's what we're working toward.

Jeff Robertson

analyst
#21

Thanks.

Jon Gibson

executive
#22

Sure. Something more, Jeff?

Jeff Robertson

analyst
#23

I suppose another follow-on to that — clearly there's plenty of discussion around carbon capture and storage — do you folks have anything, whether via chemistry or data analytics, that you're developing, that you're assessing among those kinds of possible fresh opportunities?

John Gibson

executive
#24

CCS, carbon capture sequestration, has really become CCUS — these days most people care about utilization rather than merely sequestration. We're working on that; what I mean is, CO2's injectability can be improved through our chemistry. So we're examining solutions to assist with injection rates and with getting a reservoir ready to accept CO2; then figuring out which chemistries suit that setting best; that's a prospect we're reviewing and we believe it will grow. We're quite lucky to be having this conversation in the Texas Gulf Coast region, since the Bureau Economic Geology at Texas pinpointed nearly a year's worth of sequestration reservoirs in the near offshore of Miocene within the state of Texas. So I believe it would be on the order of 35 gigatons that could go into depleted fields offshore that we know could contain it, given they contained natural gas for hundreds of years, for 1000s of years. And so I think as that infrastructure develops, the Texas Gulf Coast will be a major part of it. Secondly, we'll be injecting into saltwater brent and I doubt we'd have sufficient work to truly say much about that right now. Yet it appears there's such an enormous volume of saltwater reservoirs onshore in North America that if we can capture it economically, we can inject it with no trouble. The actual challenge here lies in CO2 Capture rather than injection in the subsurface, which will be part of that answer. But I think the larger trigger, and the one, or the node, that must be cleared is how we'll capture it more efficiently.

Eric Swergold

analyst
#25

Eric, two additional items from me. To build on what we discussed regarding CO2, could you share anything about your activities involving methane? It appears to be a major area of attention under several of the newer environmental rules.

John Gibson

executive
#26

John: Sure. In our lab, we've run a number of tests focused on the way we might detect different gases or molecules using JP3 analyzers, and that effort is ongoing. We partnered with one specific customer to evaluate whether it was viable, and results looked very promising. What this does mean is that our analyzers would need to be expanded, since the spectrum range we're currently scanning likely isn't optimal for detecting CO2 or methane. Even so, it represents a strong opportunity at relatively low cost, given that we already possess all the knowledge required to install additional monitors within our existing box to detect those extra molecules, or to boost the sweet frequency in a later version of the device. Every one of those items is in progress, Eric. My sense is that both the environmental aspect and the regulatory landscape will favor us broadening the set of things we can measure. As a result, we have ongoing active work in this space. It's not yet at a stage where I could tell you which quarter, but we keep monitoring it, and it's a key component of what lies ahead.

Eric Swergold

analyst
#27

All right. Then going back to ADM. I'm not certain whether this is something we can talk about or not. But could there be room for margin gains? And after exiting that unfavorable ADM contract with respect to your cost of goods sold moving forward? Now that you've sort of left that old contract behind, should your CNF business be in a position to get a better margin?

John Gibson

executive
#28

Great question. I'm seated here glancing at my General Counsel, ensuring I don't breach any of the settlement agreements. But there was an uplift and cost tied to a terpene we were purchasing regardless of what the market price was. There were fixed fees we had to pay on top of that, and that's definitely going to return to us since we'll be purchasing it on the market without that uplift. And that is material, I mean, so it ought to provide some impact. Now, obviously, we blend that with other chemicals. And so the real margin effect becomes diluted to some extent, just like it gets diluted in the blend. And we're utilizing less of it in our blends than we did previously. So as a result, we're not passing through as much; that's one reason we had to exit the contract. But it ought to deliver some margin improvement. And it definitely brings us back to open market pricing, which I believe will be a tremendous opportunity for us.

Eric Swergold

analyst
#29

Then for my final question, it concerns ESG overall. During the prior quarter, you made a significant enhancement to the corporate presentation regarding spreading awareness about ESG. Could you provide an update on the current status of that ESG initiative from an investor relations standpoint, since I recall you saying near the start of this call that making inroads into corporate boardrooms doesn't produce instant change, though those boards are paying attention to ESG.

John Gibson

executive
#30

On ESG, I'll have Ryan chime in here, along with James regarding the impressive scorecards at Basin. We still haven't received that update to the deck for investors, but later today we intend to get to work on it. A few developments are taking place that I find quite exciting. First, we've been making sales to suppliers operating within the geothermal sector. That fits squarely within ESG, and as you're aware, you cannot drill a geothermal well and claim to be a green power provider if you somehow breach ESG principles while preparing those wells to circulate fluids coming from beneath the surface. So I believe that will be an excellent space for us. We currently have many discussions underway, and across the coming months, we'll be speaking with geothermal drillers as well as geothermal startups. That's a space where considerable capital is moving around. Additionally, regarding ESG, I believe a key reason people are genuinely engaging with us at the C-suite level is simply how deeply embedded ESG has become within our DNA, and with that, I'll pass things to Ryan and James so they can tell you our position on the scorecard, and less so on the investor side. So your question amounts to whether we've succeeded with the green investor so far, and my answer would be no, Eric, and that presents an opportunity for me during the upcoming quarter.

Ryan Ezell

executive
#31

Let me give a bit more detail about the way we're going after both our current customers and the ones we hope to have. Over the past 2 quarters, we've held more than 25 meetings with a range of what I'd call asset owners — people at the C-suite level, along with engineering and chemistry technical teams — focused on how the chemistry scorecard and the ESG scorecard get applied. What we've actually done is take a hard look at this: we've gone out to our biggest customers and run assessments for them, and we've also worked with the companies we regard as leaders in the industry when it comes to responsible drilling and production of oil and gas. Beyond that, we've reached out to certain businesses that operate outside oil and gas or energy altogether — purely in industrial chemicals — and talked with them about the way the scorecard functions and the sort of impact it delivers, since this has grown out of annual sustainability reporting into something broader: how it also shapes operational efficiency and, on top of that, risk management as a whole. James's team has been out front in taking the insights we're gathering from customers and prospective customers and carrying them over to the reporting bodies. You mentioned SASB and equitable origin — how the two fit together to produce a genuinely analytical answer. That carries through into investment possibilities with banks, when it comes to examining Enterprise Risk Management across entire assets. I'd say the engagement has been excellent, and we keep learning and developing on this front while watching value get generated through applying the scorecard. So it isn't merely a figure for an annual sustainability report; it's a genuine assessment and analysis of chemical utilization across the full life cycle.

John Gibson

executive
#32

That's actually a solid point you're raising. And when we speak again in three months, Eric, I'll come back to you with a figure — this isn't a two-company situation — on how many pitches we've delivered to green investment groups, and we'll frame it as a goal to be completed rather than something dependent on access.

John Gibson

executive
#33

There's a ton of thrilling activity going on in this sector; and especially when it comes to services, consolidation is taking place, like I said, and the major players here who have proven histories of genuinely expanding businesses and finding success — our plan is to follow that same path. So the future has us energized; we're thankful to each of our shareholders, and I'm especially thankful to our finance group, we appear to keep shifting legacy problems and other matters around; so I'm grateful for how dependable our financials are and our capacity to resolve material weaknesses and then the extremely tight collaboration we maintain with our auditors. This is a wonderful company we have; even so, there's a hill ahead for us to climb; and I believe our next call will be the one where we truly dig into the specifics regarding cash and what lies ahead concerning liquidity and what we've carried out and what we're carrying out now. Once more, I truly appreciate you all sticking with us. And it's been a fascinating quarter; yet I believe Q4 is genuinely going to establish the groundwork for what we ought to expect in 2022 and just like every other CEO in this space, right now I'm enthusiastic about the coming year and I look forward to the next call. Thank you very much.

Operator

operator
#34

That wraps up this call. We appreciate everyone joining us for today's presentation. You're free to leave the line now.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Flotek Industries, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Flotek Industries, Inc. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Flotek Industries, Inc. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.